>
Hera Med logo

HMD - Hera Med Share Price

A$0.155 0.0  3.3%

Last Trade - 14/05/21

Sector
Healthcare
Size
Micro Cap
Market Cap £12.8m
Enterprise Value £11.6m
Revenue £28.1k
Position in Universe 1437th / 1911
Bullish
Bearish
Unlock HMD Revenue
Momentum
Relative Strength (%)
1m +35.5%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -22.5%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.000 0.000 0.000 0.077 0.15 0.040
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020, Hera MedLtd revenues decreased 73% to $40K. Net loss increased 7%to $3.4M. Revenues reflect a decrease in demand for theCompany's products and services due to unfavorable marketconditions. Higher net loss reflects Research anddevelopment expenses increase of 28% to $1.2M (expense),General and administrative expenses increase of 3% to $963K(expense), Finance income decrease of 65% to $13K (income).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

HMD Revenue Unlock HMD Revenue

Net Income

HMD Net Income Unlock HMD Revenue

Normalised EPS

HMD Normalised EPS Unlock HMD Revenue

PE Ratio Range

HMD PE Ratio Range Unlock HMD Revenue

Dividend Yield Range

HMD Dividend Yield Range Unlock HMD Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
HMD EPS Forecasts Unlock HMD Revenue
Profile Summary

Hera Med Ltd is an Israel-based company that develops pregnancy monitoring solutions for home and professional use. It offers hardware solutions supported by software applications. Its product HeraBEAT, is a medical-grade, clinically-validated and connected Ultrasound Fetal Doppler device predominantly for use by an expectant mother to self-monitor her fetus’ heart rate (FHR) at home. HeraBEAT communicates with any smartphone (iOS/Android) through Bluetooth Low Energy (BLE). A mother can hold or strap the HeraBEAT device to her abdomen, and the collected data is transmitted to her smartphone where the relevant readings are displayed through an interface. The Company also develops a service model which includes a homecare pregnancy solution. In addition, the Company develops artificial intelligence (AI), machine-learning, computerized algorithms to monitor and analyze the data so a healthcare professional or home user is informed of the wellbeing of the fetus.

Directors
Last Annual December 31st, 2020
Last Interim December 31st, 2020
Incorporated October 5, 2011
Public Since December 12, 2018
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index
Exchange Australian Stock Exchange - SEATS
Shares in Issue 150,038,908
Free Float (0.0%)
Eligible for
ISAs
SIPPs
HMD Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for HMD
Upcoming Events for HMD
Wednesday 14th July, 2021 Estimate
Hera Med Ltd Annual Shareholders Meeting
Frequently Asked Questions for Hera Med
What is the Hera Med share price?

As of 14/05/21, shares in Hera Med are trading at A$0.155, giving the company a market capitalisation of £12.8m. This share price information is delayed by 15 minutes.

How has the Hera Med share price performed this year?

Shares in Hera Med are currently trading at A$0.155 and the price has moved by 47.62% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Hera Med price has moved by 10.48% over the past year.

What are the analyst and broker recommendations for Hera Med?

There are no analysts currently covering Hera Med.

When will Hera Med next release its financial results?

Hera Med is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Hera Med dividend yield?

Hera Med does not currently pay a dividend.

Does Hera Med pay a dividend?

Hera Med does not currently pay a dividend.

When does Hera Med next pay dividends?

Hera Med does not currently pay a dividend.

How do I buy Hera Med shares?

To buy shares in Hera Med you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Hera Med?

Shares in Hera Med are currently trading at A$0.155, giving the company a market capitalisation of £12.8m.

Where are Hera Med shares listed? Where are Hera Med shares listed?

Here are the trading details for Hera Med:

Country of listing: Australia
Exchange: ASX
Ticker Symbol: HMD
What kind of share is Hera Med?

Based on an overall assessment of its quality, value and momentum, Hera Med is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Hera Med share price forecast 2021?

We were not able to load any forecast data for Hera Med.

How can I tell whether the Hera Med share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Hera Med. Over the past six months, the relative strength of its shares against the market has been 24.5%. At the current price of A$0.155, shares in Hera Med are trading at 25.21% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Hera Med PE Ratio?

We were not able to find PE ratio data for Hera Med.

Who are the key directors of Hera Med?

We were unable to find the directors for Hera Med.

Who are the major shareholders of Hera Med?

Here are the top five shareholders of Hera Med based on the size of their shareholding:

Holley Pharmaceutical Group Co., Ltd. Corporation
Percentage owned: 6.15% (10.9m shares)
Altor Capital Management Pty. Ltd. Corporation
Percentage owned: 6.14% (10.9m shares)
Slonim (Tal) Individual Investor
Percentage owned: 5.23% (9.25m shares)
Groberman (David) Individual Investor
Percentage owned: 5.23% (9.25m shares)
Freeman Road Pty. Ltd. Corporation
Percentage owned: 3.91% (6.91m shares)
Similar to HMD
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.